Book contents
- Neuromuscular Disease: A Case-Based Approach
- Neuromuscular Disease
- Copyright page
- Contents
- Contributors
- Foreword
- Preface to 2nd Edition
- Part I Evaluation and Treatment of Patients with a Neuromuscular Disorder
- Part II Neuromuscular Cases
- Disorders of the Anterior Horn Cell
- Peripheral Neuropathies
- Disorders of the Neuromuscular Junction
- Case 31 Myasthenia Gravis with Acetylcholine Receptor Antibodies (AChR MG)
- Case 32 Myasthenia Gravis with Muscle-Specific Kinase Antibodies (MuSK MG)
- Case 33 Drug-Induced Myasthenia Gravis: Immune Checkpoint Inhibitor (ICI)-Related
- Case 34 Lambert–Eaton Myasthenic Syndrome (LEMS)
- Case 35 Congenital Myasthenic Syndromes (CMS): Dok7
- Myopathies
- Video legends
- Index
- References
Case 31 - Myasthenia Gravis with Acetylcholine Receptor Antibodies (AChR MG)
from Disorders of the Neuromuscular Junction
Published online by Cambridge University Press: aN Invalid Date NaN
Book contents
- Neuromuscular Disease: A Case-Based Approach
- Neuromuscular Disease
- Copyright page
- Contents
- Contributors
- Foreword
- Preface to 2nd Edition
- Part I Evaluation and Treatment of Patients with a Neuromuscular Disorder
- Part II Neuromuscular Cases
- Disorders of the Anterior Horn Cell
- Peripheral Neuropathies
- Disorders of the Neuromuscular Junction
- Case 31 Myasthenia Gravis with Acetylcholine Receptor Antibodies (AChR MG)
- Case 32 Myasthenia Gravis with Muscle-Specific Kinase Antibodies (MuSK MG)
- Case 33 Drug-Induced Myasthenia Gravis: Immune Checkpoint Inhibitor (ICI)-Related
- Case 34 Lambert–Eaton Myasthenic Syndrome (LEMS)
- Case 35 Congenital Myasthenic Syndromes (CMS): Dok7
- Myopathies
- Video legends
- Index
- References
Summary
A 70-year-old woman was referred by her GP because of progressive nasal speech and difficulties with chewing and swallowing, shortly after abdominal surgery because of a borderline malignant cystoadenofibroma of the uterus. Weeks later, she also noticed drooping of both eyelids and a tendency for her head to drop at the end of a day. In retrospect, mild nasal speech had been present for some months prior to surgery.
Keywords
- Type
- Chapter
- Information
- Neuromuscular DiseaseA Case-Based Approach, pp. 157 - 160Publisher: Cambridge University PressPrint publication year: 2024
References
Suggested Reading
Doughty, CT, Guidon, AC. Diagnostic testing for ocular myasthenia gravis: stronger together. Neurology 2020;95(13):563–564. doi: 10.1212/WNL.0000000000010616. Epub 2020 Aug 11. PMID: 32788244.CrossRefGoogle Scholar
Gilhus, NE. Myasthenia gravis can have consequences for pregnancy and the developing child. Front Neurol 2020;11:554. doi: 10.3389/fneur.2020.00554. PMID: 32595594; PMCID: PMC7304249.CrossRefGoogle ScholarPubMed
Gilhus, NE, Tzartos, S, Evoli, A, et al. Myasthenia gravis. Nat Rev Dis Primers 2019;5(1):30. doi: 10.1038/s41572-019-0079-y. PMID: 31048702.CrossRefGoogle ScholarPubMed
Menon, D, Bril, V. Pharmacotherapy of generalized myasthenia gravis with special emphasis on newer biologicals. Drugs 2022;82(8):865–887. doi: 10.1007/s40265-022-01726-y. Epub 2022 May 31. PMID: 35639288; PMCID: PMC9152838.CrossRefGoogle ScholarPubMed
Narayanaswami, P, Sanders, DB, Wolfe, G, et al. International consensus guidance for management of myasthenia gravis: 2020 Update. Neurology 2021;96(3):114–122. doi: 10.1212/WNL.0000000000011124. Epub 2020 Nov 3. PMID: 33144515; PMCID: PMC7884987.CrossRefGoogle ScholarPubMed
Vanoli, F, Mantegazza, R. Current drug treatment of myasthenia gravis. Curr Opin Neurol 2023;36(5):410–415. doi: 10.1097/WCO.0000000000001196. Epub 2023 Aug 30. PMID: 37678337.CrossRefGoogle ScholarPubMed
Verschuuren, JJ, Palace, J, Murai, H, et al. Advances and ongoing research in the treatment of autoimmune neuromuscular junction disorders. Lancet Neurol 2022;21(2):189–202. doi: 10.1016/S1474-4422(21)00463-4. Erratum in: Lancet Neurol 2022 Mar;21(3):e3. PMID: 35065041.CrossRefGoogle ScholarPubMed